icd 9 code for psa test

by Kariane Upton 10 min read

ICD-9 code 790.93 for Elevated prostate specific antigen [PSA] is a medical classification as listed by WHO under the range -NONSPECIFIC ABNORMAL FINDINGS (790-796).

What ICD-10 code covers PSA test?

Report HCPCS Level II code G0102 Prostate cancer screening; digital rectal examination or G0103 Prostate cancer screening; prostate specific antigen test (PSA), total, as appropriate, with ICD-10-CM diagnosis code Z12. 5 Encounter for screening for malignant neoplasm of prostate (ICD-9-CM V76.Sep 28, 2015

What diagnosis will cover a PSA?

prostate cancerPSA when used in conjunction with other prostate cancer tests, such as digital rectal examination, may assist in the decision making process for diagnosing prostate cancer. PSA also, serves as a marker in following the progress of most prostate tumors once a diagnosis has been established.

What is the ICD code for PSA?

R97.2Elevated prostate specific antigen [PSA] The 2022 edition of ICD-10-CM R97. 2 became effective on October 1, 2021.

What is the ICD-9 code for elevated PSA?

ICD-9 code 790.93 and ICD-10 code R07. 2 indicate an elevated prostate-specific antigen (PSA). A PSA level is considered elevated when determined as elevated by the attending urologist not only by the determined level itself.

Is a PSA test considered preventive?

Aetna considers prostate-specific antigen (PSA) screening a medically necessary preventive service for men 45 years of age and older who are considered average-risk for prostate cancer, and for men 40 years of age and older who are considered at high-risk for prostate cancer.

What are ICD-9 and ICD-10 codes?

Code Structure: Comparing ICD-9 to ICD-10ICD-9-CMICD-10-CMConsists of three to five digitsConsists of three to seven charactersFirst character is numeric or alpha ( E or V)First character is alphaSecond, Third, Fourth and Fifth digits are numericAll letters used except U3 more rows•Aug 24, 2015

What does ICD-9 stand for in medical terms?

International Classification of Diseases,Ninth RevisionInternational Classification of Diseases,Ninth Revision (ICD-9) Related Pages. The International Classification of Diseases (ICD) is designed to promote international comparability in the collection, processing, classification, and presentation of mortality statistics.

What is a category code?

Category codes are user defined codes to which you can assign a title and a value. The title appears on the appropriate screen next to the field in which you type the code.

What is the N40 code for prostate?

Screening may detect nodules or other abnormalities of the prostate. Benign prostatic hyperplasia or hypertrophy, enlarged prostate , or nodular prostate are common conditions code in category N40. The 4 th digit is used to describe the condition and/or the presence of associated lower urinary tract symptoms as follows:

What drugs lower PSA?

Factors which might lower PSA level – even if the man has prostate cancer: 5-alpha reductase inhibitors: Certain drugs used to treat BPH or urinary symptoms, such as finasteride (Proscar or Propecia) or dutasteride (Avodart), can lower PSA levels.

How many people die from prostate cancer each year?

It affects roughly 1.3 million people and kills more than 360,000 people each year, which represents about 4% of all cancer deaths worldwide. In its early stages, prostate cancer is highly treatable, with five-year survival rates close ...

How long does prostate cancer last?

In its early stages, prostate cancer is highly treatable, with five-year survival rates close to 100%. Once prostate cancer has metastasized, however, the 5-year survival rate falls to less than 30%, highlighting a significant need for more effective treatment of advanced stage disease. Because prostate cancer is highly curable when detected in ...

What is the treatment for prostate cancer?

Conventional treatments for early-stage prostate cancer include surgery and radiation. Hormonal therapy, which can reduce levels of the male hormones (androgens like testosterone) that lead to tumor growth, is also used to treat early-stage tumors.

How often does Medicare cover prostate cancer screening?

Medicare provides coverage of an annual preventive prostate cancer screening PSA test and DRE once every 12 months for all male beneficiaries age 50 and older (coverage begins the day after the beneficiary's 50th birthday), if at least 11 months have passed following the month in which the last Medicare-covered screening DRE or PSA test was performed for the early detection of prostate cancer.

What is a laparoscopy?

Laparoscopy, surgical prostatectomy, retropubic radical, including nerve sparing, includes robotic assistance, when performed. These codes require careful review of the surgical documentation to determine whether the surgery was partial or total, open or laparoscopic, or included other procedures.

What is the diagnosis code for malignant neoplasm of prostate?

For a screening test for a patient with no signs or symptoms of disease, use diagnosis code Z12.5 Encounter for screening for malignant neoplasm of prostate. If you report another diagnosis code with G0103, Medicare will not pay for it. You must use a screening diagnosis with a screening CPT® code.

What happens if you don't have a PSA?

Prostate specific antigen (PSA) screenings are commonplace in most urology practices, which means if you don’t have your procedure and diagnosis coding straight, you may face high denial rates and possibly significant revenue loss. Avoid those pitfalls with these three tips.

Do you have to check the PSA code before submitting a claim?

Once you decide on the codes , there’s one more point to check before submitting the claim: Payers have tight restrictions on the frequency for which they will pay for PSA tests.

How often is a PSA test covered by Medicare?

Screening PSA tests are covered at a frequency of once every 12 months for men who have attained age 50 (i.e., starting at least one day after they have attained age 50), if at least 11 months have passed following the month in which the last Medicare-covered screening prostate specific antigen test was performed.

What is prostate specific antigen?

Prostate Specific Antigen (PSA), a tumor marker for adenocarcinoma of the prostate, can predict residual tumor in the post-operative phase of prostate cancer. Three to 6 months after radical prostatectomy, PSA is reported to provide a sensitive indicator of persistent disease.

How often does Medicare cover prostate cancer screening?

Medicare provides coverage of an annual preventive prostate cancer screening PSA test and DRE once every 12 months for all male beneficiaries age 50 and older (coverage begins the day after the beneficiary’s 50th birthday), if at least 11 months have passed following the month in which the last Medicare-covered screening DRE or PSA test was performed for the early detection of prostate cancer.

image

Tip 1 – Determine Screening Or Diagnostic

Tip 2 – Choose The Supporting Diagnosis Codes

  • For a screening test for a patient with no signs or symptoms of disease, use diagnosis code Z12.5 Encounter for screening for malignant neoplasm of prostate. If you report another diagnosis code with G0103, Medicare will not pay for it. You must use a screening diagnosis with a screening CPT® code. When the urologist orders a diagnostic PSA test an...
See more on aapc.com

Tip 3 – Watch Out For Frequency Limits

  • Once you decide on the codes, there’s one more point to check before submitting the claim: Payers have tight restrictions on the frequency for which they will pay for PSA tests. Medicare, for example, covers screening PSA tests once every 12 months for men age 50 years and older, as instructed in the Claims Processing Manual, Chapter 18, Section 50. Be sure at least 11 months …
See more on aapc.com